Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Biventricular pacing for heart failure.

S V Pavia1, B L Wilkoff

  • 1Section of Cardiac Pacing and Electrophysiology, Department of Cardiology, Cleveland Clinic Foundation, Cleveland, Ohio, USA.

Cardiology Clinics
|November 22, 2001
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Active fixation mechanism complicates coronary sinus lead extraction and limits subsequent reimplantation targets.

Journal of interventional cardiac electrophysiology : an international journal of arrhythmias and pacing·2012
Same author

Artefact mimicking tachycardia during magnetic resonance imaging in a patient with an implantable loop recorder.

Heart (British Cardiac Society)·2003
Same author

Assessment of pacemaker chronotropic response: implementation of the Wilkoff mathematical model.

Pacing and clinical electrophysiology : PACE·2002
Same author

Life-threatening ventricular arrhythmias due to transient or correctable causes: high risk for death in follow-up.

Journal of the American College of Cardiology·2001
Same author

Relationship between rehospitalization and future death in patients treated for potentially lethal arrhythmia.

Journal of cardiovascular electrophysiology·2001
Same author

Correlation of impedance minute ventilation with measured minute ventilation in a rate responsive pacemaker.

Pacing and clinical electrophysiology : PACE·2001
Same journal

At the Edge of the Possible: A New Standard for Cardiovascular Critical Care.

Cardiology clinics·2026
Same journal

End-of-Life Care in the Cardiovascular Intensive Care Unit.

Cardiology clinics·2026
Same journal

Strategies to Reduce Failure to Rescue after Cardiac Surgery.

Cardiology clinics·2026
Same journal

Embracing Enhanced Recovery After Cardiac Surgery Program.

Cardiology clinics·2026
Same journal

Post-Heart Transplantation Intensive Care Unit Recovery: A Phase-Based Approach.

Cardiology clinics·2026
Same journal

A Practical Guide to Intensive Care Unit Management after Left Ventricular Assist Device Implantation.

Cardiology clinics·2026
See all related articles

Biventricular pacing shows promise for congestive heart failure symptoms. Optimal medical therapy is crucial before considering this novel treatment, with further research needed on patient selection and mortality benefits.

Area of Science:

  • Cardiology
  • Medical Devices

Background:

  • Congestive heart failure (CHF) is a debilitating condition with significant symptom burden.
  • Biventricular pacing (BVP) has emerged as a potential novel therapy for CHF management.

Purpose of the Study:

  • To evaluate the efficacy of biventricular pacing in managing congestive cardiac failure symptoms.
  • To identify optimal patient selection criteria and refine hardware delivery for BVP therapy.

Main Methods:

  • Review of completed clinical trials on biventricular pacing in CHF patients.
  • Assessment of patient response to BVP and identification of non-responders.
  • Consideration of medical therapy as a prerequisite for BVP assessment.

Main Results:

Related Experiment Videos

  • BVP therapy demonstrates encouraging results for CHF symptoms.
  • Not all CHF patients respond favorably to BVP, necessitating refined patient selection.
  • Maximally tolerated medical therapy is recommended before and after BVP implantation.

    • Conclusions:

    • BVP is a promising novel therapy for CHF, but requires further refinement in hardware delivery and patient selection.
    • Medical therapy should be optimized before considering BVP, and the two approaches may be complementary.
    • Future trials should assess the impact of BVP on mortality and the need for defibrillation capability in CHF patients.